Protective efficacy of orally delivered bovine milk immunoglobulin (BIgG) specific for the minor CFA/I [colonisation factor antigen I] fimbrial adhesin CfaE against challenge with H10407 enterotoxigenic E. coli [Escherichia coli] (ETEC) strain expressing CFA/I
Phase of Trial: Phase I
Latest Information Update: 03 Nov 2017
At a glance
- Drugs Bovine anti-Escherichia coli immunoglobulin (Primary)
- Indications Escherichia coli infections
- Focus Adverse reactions
- 20 Mar 2007 New trial record.